Table 3 Shown are the indications for liver transplantation in the study population
From: Prognostic limitations of the Eurotransplant-donor risk index in liver transplantation
Indications for liver transplantation: | % |
|---|---|
acute liver failure | 10.3 |
alcoholic cirrhosis | 8.6 |
alpha-1-antitrypsin deficiency | 1.4 |
autoimmune hepatitis | 1.0 |
biliary atresia | 0.7 |
Budd Chiari syndrome | 2.1 |
cryptogenic cirrhosis | 5.5 |
familial amyloidotic polyneuropathy | 1.0 |
HBV HCV related cirrhosis | 0.3 |
HBV related cirrhosis | 4.5 |
HCC | 19.6 |
HCV related cirrhosis | 5.5 |
intrahepatic CCC | 0.7 |
M. Osler/hemangioma | 0.3 |
neuroendocrine metastases | 1.0 |
Other | 0.7 |
Oxalosis | 0.3 |
PBC | 2.7 |
polycystic disease | 3.4 |
PSC | 8.2 |
re-TX: biliary complications | 3.4 |
re-TX: chronic graft failure | 5.5 |
re-TX: chronic rejection | 1.0 |
re-TX: primary graft non-function | 6.2 |
re-TX: recurrent viral hepatitis | 0.3 |
re-TX: vascular complications | 2.4 |
secondary biliary cirrhosis | 1.7 |
Wilson disease | 1.4 |
Total: | 100.0 |